Appropriate Clinical Application of Thrombocytes Concentrate
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Ayupova R., Sultanbaev U., Zhiburt E. 2017. Effectiveness of multiple platelet transfusion. Hematology. Transfusiology. Eastern Europa. 3(1): 30–7.
AABB Standards for Blood Banks and Transfusion Services, 30th ed. AM ASSN BLOOD, 2016: 120 p.
AABB Technical Manual. 2014. Fung MK. (ed. ) 18th ed. AABB Press: Bethesda, Maryland: 1044 p.
Cooper N., Bein G., Heidinger K. et al. 2016. A bead-based assay in the work-up of suspected platelet alloimmunization. Transfusion. 56(1): 115–18. https://doi.org/10.1111/trf.13351
Guide to the preparation, use and quality assurance of blood components: Recommendation No. R (95) 15. – 19th ed. – European directorate for the Quality of medicines & HealthCare: Strasbourg, 2017: 540 p. PDF
Hauck-Dlimi B., Ruppel R., Zimmermann R. et al. 2016. Transfusion-related alloimmune neutropenia with no pulmonary complications: one donor – five cases. Transfusion. 56 (1): 84–90. https://doi.org/10.1111/trf.13333
Heyman MR., Schiffer CA. 1990. Platelet transfusion therapy for the cancer patiеnt. Semin. Oncol. 17(2): 198–209.
Hematology: national guide. 2015. Rukavitsyn OA. (ed.). Moskow: GEOTARMedia: 776 p.
Jatzalauk G., Althraus K., Strobel U. et al. 2016 Flucloxacillin-induced immune thrombocytopenia. Transfusion. 56(1): 67–72. https://doi.org/10.1111/trf.13284
McCullough J., Goldfinger D., Gorlin J. et al. 2015. Cost implications of implementation of pathogen-inactivated platelets. Transfusion. (55)10: 2312–20. https://doi.org/10.1111/trf.13149
Marik P. E., Corwin H. L. 2008. Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature. Crit Care Med. 36(9): 2667–74. https://doi.org/10.1097/CCM.0b013e3181844677
Marshall AL, Goodarzi K., Kuter D.J. 2015. Romiplostim in the management of the thrombocytopenic surgical patient. Transfusion. (55)10: 2505–10. https://doi.org/10.1111/trf.13181
Meinke S., Sandgren P., Mortberg A., et al. 2016. Platelets made HLA deficient by acid treatment aggregate normally and escape destruction by complement and phagocytes in the presence of HLA antibodies. Transfusion. (56)2: 370–82. https://doi.org/10.1111/trf.13350
Perekhrestenko P., Timchenko A., Maligon O. et al. 2018. Indices of of activity of blood service in Ukraine in 2017. Kyiv: TOV “DIA”: 76 p.
Raynel S., Padula MP, Marks DC, Jonson L. 2015. Cryopreservation alters the membrane and cytoskeletal protein profile of microparticles. Transfusion. (55)10: 2422–31. https://doi.org/10.1111/trf.13165
Riviere E., Saint-Leger M., James C. et al. 2015. Platelet transfusion and catheter insertion for plasma exchange in patients with thrombotic thrombocytopenic purpura and a low platelet count. Transfusion. (55)7: 1798–02. https://doi.org/10.1111/trf.13041
Rumyantsev A., Madzaev S., Fillina N. et al. 2015. Platelet transfusion effectiveness. Hematology. Transfusiology. Eastern Europa. 2(02): 16–24.
Slichter SJ. 1990. Platelet transfusion therapy. Hematol. Onсol. Clin. North Am. 4(1): 291–311. https://doi.org/10.1016/S0889-8588(18)30517-3
Slot E., Janssen MP, Marsjt-van der Kreek T. et al. 2016. Two decades of risk factors and transfusion-transmissible infections in Dutch blood donors. Transfusion. (56)1: 203–14. https://doi.org/10.1111/trf.13298
Transfusion medicine. 2017. Mc-Cullough J. (ed.) 4th ed. Wiley Blackwell. 603 p.
Transfusiology: national guide. 2012. Ragimov AA. (Ed.). Moskow: GEOTARMedia: 1184 p.
Vande Vusse LK., Madtes DK., Bolgiano D., Watkins TR. 2016. The association between platelet transfusion and idiopathic pneumonia syndrome is unaffected by platelet product type. Transfusion. 56(2): 489–96. https://doi.org/10.1111/trf.13361
Сlinical oncohematology. A manual for the physician. 2007. Ed. by M. A. Volkova. 2nd edition, updated. Moskow: Meditsina Publichers: 1120 p.
Vahanova T., Gerasimchyk P. 2017. Clinical Transfusiology, management of blood components and preparations for patients. Hematology. Transfusiology. Eastern Europa. 4(3): 653–660.
Vydyborets S. V. 2018. West Nile virus infection is a new type of hemotransfusion infection. Hematology. Transfusiology. Eastern Europa. 4(1): 85–90.
Vydyborets SV., Andriiaka AO. 2016. Syndrome of transfusion acute lung injury. Hematology. Transfusiology. Eastern Europa. 2(4): 473–84.
Vydyborets SV., Gaidukova SN. 2017. Posttransfusion reactions and complications. Hematology. Transfusiology. Eastern Europa. 3(1): 67–81.
Vydyborets SV., Gaidukova SN., Muliarchuk OV. 2018. Platelets: structure and function. Family medicine. 2(76): 103–8. https://doi.org/10.30841/2307-5112.2.2018.146042
Waterman YR., Kapp LM., Munday A. et al. 2016. Transfusion-induced alloimmunization and platelet refractoriness in a mouse model: mechanism and intervention. Transfusion. 56(1): 91–100. https://doi.org/10.1111/trf.13270
